4//SEC Filing
ARADIGM CORP 4
Accession 0001123292-17-000825
CIK 0001013238operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 1:06 PM ET
Size
5.1 KB
Accession
0001123292-17-000825
Insider Transaction Report
Form 4
ARADIGM CORPARDM
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-04-04$1.51/sh−3,765$5,685→ 85,129 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2016.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.54 per share and is rounded up to the next whole number. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
ARADIGM CORP
CIK 0001013238
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001013238
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 1:06 PM ET
- Size
- 5.1 KB